{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Timosaponin-AIII", "angiogenesis", "anticancer", "apoptosis", "autophagy", "multidrug resistance", "steroid saponin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37513375", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "19"}], "Language": ["eng"], "ELocationID": ["5500", "10.3390/molecules28145500"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "14", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "19"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment.", "Abstract": {"AbstractText": ["Cancer, as one of the leading causes of death worldwide, has challenged current chemotherapy drugs. Considering that treatments are expensive, alongside the resistance of tumor cells to anticancer drugs, the development of alternative medicines is necessary. <i>Anemarrhena asphodeloides</i> Bunge, a recognized and well-known medicinal plant for more than two thousand years, has demonstrated its effectiveness against cancer. Timosaponin-AIII (TSAIII), as a bioactive steroid saponin isolated from <i>A. asphodeloides</i>, has shown multiple pharmacological activities and has been developed as an anticancer agent. However, the molecular mechanisms of TSAIII in protecting against cancer development are still unclear. In this review article, we provide a comprehensive discussion on the anticancer effects of TSAIII, including proliferation inhibition, cell cycle arrest, apoptosis induction, autophagy mediation, migration and invasion suppression, anti-angiogenesis, anti-inflammation, and antioxidant effects. The pharmacokinetic profiles of TSAII are also discussed. TSAIII exhibits efficacy against cancer development. However, hydrophobicity and low bioavailability may limit the application of TSAIII. Effective delivery systems, particularly those with tissue/cell-targeted properties, can also significantly improve the anticancer effects of TSAIII."]}, "AuthorList": [{"Identifier": ["0009-0005-9603-5092"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou 341000, China."}], "LastName": "Liu", "ForeName": "Zhaowen", "Initials": "Z"}, {"Identifier": ["0009-0003-6165-5940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou 341000, China."}], "LastName": "Cao", "ForeName": "Yifan", "Initials": "Y"}, {"Identifier": ["0009-0005-2969-9956"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou 341000, China."}], "LastName": "Guo", "ForeName": "Xiaohua", "Initials": "X"}, {"Identifier": ["0000-0003-2487-707X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gannan Medical University, Ganzhou 341000, China."}], "LastName": "Chen", "ForeName": "Zhixi", "Initials": "Z"}], "GrantList": [{"GrantID": "81960883", "Agency": "National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Steroids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Steroids"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy", "prevention & control"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Saponins"}, {"QualifierName": [], "DescriptorName": "Anemarrhena"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\u00c7etinkaya M., Baran Y. Therapeutic Potential of Luteolin on Cancer. Vaccines. 2023;11:554. doi: 10.3390/vaccines11030554.", "ArticleIdList": ["10.3390/vaccines11030554", "PMC10057337", "36992138"]}, {"Citation": "Saraswathy M., Gong S. Different strategies to overcome multidrug resistance in cancer. Biotechnol. Adv. 2013;31:1397\u20131407. doi: 10.1016/j.biotechadv.2013.06.004.", "ArticleIdList": ["10.1016/j.biotechadv.2013.06.004", "23800690"]}, {"Citation": "Sleire L., F\u00f8rde H.E., Netland I.A., Leiss L., Skeie B.S., Enger P. Drug repurposing in cancer. Pharmacol. Res. 2017;124:74\u201391. doi: 10.1016/j.phrs.2017.07.013.", "ArticleIdList": ["10.1016/j.phrs.2017.07.013", "28712971"]}, {"Citation": "Megyesfalvi Z., Gay C.M., Popper H., Pirker R., Ostoros G., Heeke S., Lang C., Hoetzenecker K., Schwendenwein A., Boettiger K., et al. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. CA A Cancer J. Clin. 2023 doi: 10.3322/caac.21785.", "ArticleIdList": ["10.3322/caac.21785", "37329269"]}, {"Citation": "Liang X., Luo D., Luesch H. Advances in exploring the therapeutic potential of marine natural products. Pharmacol. Res. 2019;147:104373. doi: 10.1016/j.phrs.2019.104373.", "ArticleIdList": ["10.1016/j.phrs.2019.104373", "PMC6839689", "31351913"]}, {"Citation": "Wang Y., Dan Y., Yang D., Hu Y., Zhang L., Zhang C., Zhu H., Cui Z., Li M., Liu Y. The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology. J. Ethnopharmacol. 2014;153:42\u201360. doi: 10.1016/j.jep.2014.02.013.", "ArticleIdList": ["10.1016/j.jep.2014.02.013", "24556224"]}, {"Citation": "Ur Rahman S., Ismail M., Khurram M., Ullah I., Rabbi F., Iriti M. Bioactive Steroids and Saponins of the Genus Trillium. Molecules. 2017;22:2156. doi: 10.3390/molecules22122156.", "ArticleIdList": ["10.3390/molecules22122156", "PMC6149773", "29206216"]}, {"Citation": "Han F.Y., Song X.Y., Chen J.J., Yao G.D., Song S.J. Timosaponin AIII: A novel potential anti-tumor compound from Anemarrhena asphodeloides. Steroids. 2018;140:125\u2013130. doi: 10.1016/j.steroids.2018.09.014.", "ArticleIdList": ["10.1016/j.steroids.2018.09.014", "30296545"]}, {"Citation": "Lin Y., Zhao W.R., Shi W.T., Zhang J., Zhang K.Y., Ding Q., Chen X.L., Tang J.Y., Zhou Z.Y. Pharmacological Activity, Pharmacokinetics, and Toxicity of Timosaponin AIII, a Natural Product Isolated From Anemarrhena asphodeloides Bunge: A Review. Front. Pharmacol. 2020;11:764. doi: 10.3389/fphar.2020.00764.", "ArticleIdList": ["10.3389/fphar.2020.00764", "PMC7283383", "32581782"]}, {"Citation": "Tang Y.H., Sun Z.L., Fan M.S., Li Z.X., Huang C.G. Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice. Planta Med. 2012;78:18\u201323. doi: 10.1055/s-0031-1280268.", "ArticleIdList": ["10.1055/s-0031-1280268", "22002851"]}, {"Citation": "Tang Z., Li G., Yang J., Duan J., Qian D., Guo J., Zhu Z., Song Z. Anemarrhena asphodeloides Non-Steroidal Saponin Components Alter the Pharmacokinetic Profile of Its Steroidal Saponins in Rat. Molecules. 2015;20:11777\u201311792. doi: 10.3390/molecules200711777.", "ArticleIdList": ["10.3390/molecules200711777", "PMC6331991", "26132904"]}, {"Citation": "Yang B., Liu Z., Wang Q., Chai Y., Xia P. Pharmacokinetic comparison of seven major bioactive components in normal and depression model rats after oral administration of Baihe Zhimu decoction by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2018;148:119\u2013127. doi: 10.1016/j.jpba.2017.09.031.", "ArticleIdList": ["10.1016/j.jpba.2017.09.031", "28987996"]}, {"Citation": "Xu X.H., Li T., Fong C.M., Chen X., Chen X.J., Wang Y.T., Huang M.Q., Lu J.J. Saponins from Chinese Medicines as Anticancer Agents. Molecules. 2016;21:1326. doi: 10.3390/molecules21101326.", "ArticleIdList": ["10.3390/molecules21101326", "PMC6272920", "27782048"]}, {"Citation": "Tundis R., Bonesi M., Menichini F., Loizzo M.R. Recent Knowledge on Medicinal Plants as Source of Cholinesterase Inhibitors for the Treatment of Dementia. Mini Rev. Med. Chem. 2016;16:605\u2013618. doi: 10.2174/1389557515666150709104731.", "ArticleIdList": ["10.2174/1389557515666150709104731", "26156548"]}, {"Citation": "Wang N., Xu P., Wang X., Yao W., Wang B., Wu Y., Shou D. Timosaponin AIII attenuates inflammatory injury in AGEs-induced osteoblast and alloxan-induced diabetic osteoporosis zebrafish by modulating the RAGE/MAPK signaling pathways. Phytomedicine. 2020;75:153247. doi: 10.1016/j.phymed.2020.153247.", "ArticleIdList": ["10.1016/j.phymed.2020.153247", "32502823"]}, {"Citation": "Lim S.M., Jeong J.J., Kang G.D., Kim K.A., Choi H.S., Kim D.H. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-\u03baB and MAPK activation and restoring Th17/Treg cell balance. Int. Immunopharmacol. 2015;25:493\u2013503. doi: 10.1016/j.intimp.2015.02.016.", "ArticleIdList": ["10.1016/j.intimp.2015.02.016", "25698557"]}, {"Citation": "Lu L., Liu Y., Ding Y., Hou J., Zhang Y., Xue H., Zhang T. Preparation of highly purified timosaponin AIII from rhizoma anemarrhenae through an enzymatic method combined with preparative liquid chromatography. Nat. Prod. Res. 2016;30:2364\u20132367. doi: 10.1080/14786419.2016.1169416.", "ArticleIdList": ["10.1080/14786419.2016.1169416", "27055070"]}, {"Citation": "Xie Y., Zhou X., Pei H., Chen M.C., Sun Z.L., Xue Y.R., Tian X.T., Huang C.G. Metabolism, pharmacokinetics, and hepatic disposition of xanthones and saponins on Zhimu treatments for exploratively interpreting the discrepancy between the herbal safety and timosaponin A3-induced hepatotoxicity. Acta Pharmacol. Sin. 2018;39:1923\u20131934. doi: 10.1038/s41401-018-0012-z.", "ArticleIdList": ["10.1038/s41401-018-0012-z", "PMC6289354", "29795136"]}, {"Citation": "He Y., Hu Z., Li A., Zhu Z., Yang N., Ying Z., He J., Wang C., Yin S., Cheng S. Recent Advances in Biotransformation of Saponins. Molecules. 2019;24:2365. doi: 10.3390/molecules24132365.", "ArticleIdList": ["10.3390/molecules24132365", "PMC6650892", "31248032"]}, {"Citation": "King F.W., Fong S., Griffin C., Shoemaker M., Staub R., Zhang Y.L., Cohen I., Shtivelman E. Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress. PLoS ONE. 2009;4:e7283. doi: 10.1371/journal.pone.0007283.", "ArticleIdList": ["10.1371/journal.pone.0007283", "PMC2747272", "19789631"]}, {"Citation": "Sy L.K., Lok C.N., Wang J.Y., Liu Y., Cheng L., Wan P.K., Leung C.T., Cao B., Kwong W.L., Chang R.C., et al. Identification of \u201csarsasapogenin-aglyconed\u201d timosaponins as novel A\u03b2-lowering modulators of amyloid precursor protein processing. Chem. Sci. 2016;7:3206\u20133214. doi: 10.1039/C5SC02377G.", "ArticleIdList": ["10.1039/C5SC02377G", "PMC6005341", "29997812"]}, {"Citation": "Wang Y.Z., Feng B., Huang H.Z., Kang L.P., Cong Y., Zhou W.B., Zou P., Cong Y.W., Song X.B., Ma B.P. Glucosylation of steroidal saponins by cyclodextrin glucanotransferase. Planta Med. 2010;76:1724\u20131731. doi: 10.1055/s-0030-1249938.", "ArticleIdList": ["10.1055/s-0030-1249938", "20486072"]}, {"Citation": "Yin Y., Zhao X.C., Wang S.J., Gao P.Y., Li L.Z., Ikejima T., Song S.J. Synthesis and biological evaluation of novel sarsasapogenin derivatives as potential anti-tumor agents. Steroids. 2015;93:25\u201331. doi: 10.1016/j.steroids.2014.09.007.", "ArticleIdList": ["10.1016/j.steroids.2014.09.007", "25456170"]}, {"Citation": "Wang W., Wang D., Wang Z., Yao G., Li X., Gao P., Li L., Zhang Y., Wang S., Song S. Synthesis of new sarsasapogenin derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells. Eur. J. Med. Chem. 2017;127:62\u201371. doi: 10.1016/j.ejmech.2016.12.011.", "ArticleIdList": ["10.1016/j.ejmech.2016.12.011", "28038327"]}, {"Citation": "Liu Z., Dong X., Ding X., Chen X., Lv L., Li Y., Chai Y. Comparative pharmacokinetics of timosaponin B-II and timosaponin A-III after oral administration of Zhimu-Baihe herb-pair, Zhimu extract, free timosaponin B-II and free timosaponin A-III to rats. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2013;926:28\u201335. doi: 10.1016/j.jchromb.2013.03.003.", "ArticleIdList": ["10.1016/j.jchromb.2013.03.003", "23542670"]}, {"Citation": "Liu Y., Pu Y., Zhang T., Ding Y., Wang B., Cai Z. Rapid and Sensitive Determination of Timosaponin AIII in Rat Plasma by LC-MS/MS and Its Pharmacokinetic Application. Int. J. Mol. Sci. 2013;14:3656\u20133670. doi: 10.3390/ijms14023656.", "ArticleIdList": ["10.3390/ijms14023656", "PMC3588063", "23434663"]}, {"Citation": "Yang B., Liu Z., Hu J., Lai X., Xia P. Quantitative determination of sarsasapogenin in rat plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2016;1022:213\u2013219. doi: 10.1016/j.jchromb.2016.04.020.", "ArticleIdList": ["10.1016/j.jchromb.2016.04.020", "27107248"]}, {"Citation": "Wang H.Q., Lan F., Zhang Y.H., Xia J.E., Gong X.M., Liu M. Identification and pharmacokinetics of saponins in Rhizoma anemarrhenae after oral administration to rats by HPLC-Q-TOF/MS and HPLC-MS/MS. Acta Pharm. 2021;71:567\u2013585. doi: 10.2478/acph-2021-0033.", "ArticleIdList": ["10.2478/acph-2021-0033", "36651556"]}, {"Citation": "Li G., Tang Z., Yang J., Duan J., Qian D., Guo J., Zhu Z., Liu H. Simultaneous determination of five components in rat plasma by UPLC-MS/MS and its application to a comparative pharmacokinetic study in Baihe Zhimu Tang and Zhimu extract. Molecules. 2015;20:6700\u20136714. doi: 10.3390/molecules20046700.", "ArticleIdList": ["10.3390/molecules20046700", "PMC6272737", "25884551"]}, {"Citation": "Jia Y., Wu B., Fan M., Wang J., Huang J., Huang C. High-performance liquid chromatography-electrospray ionization tandem mass spectrometry for metabolism study of timosaponin AIII. J. Chromatogr. Sci. 2014;52:418\u2013422. doi: 10.1093/chromsci/bmt052.", "ArticleIdList": ["10.1093/chromsci/bmt052", "23696387"]}, {"Citation": "Sun Y., Liu L., Peng Y., Liu B., Lin D., Li L., Song S. Metabolites characterization of timosaponin AIII in vivo and in vitro by using liquid chromatography-mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2015;997:236\u2013243. doi: 10.1016/j.jchromb.2015.06.015.", "ArticleIdList": ["10.1016/j.jchromb.2015.06.015", "26134298"]}, {"Citation": "Wang X., Yu Y., Pei L., Gao H. Comparison of the pharmacokinetics of timosaponin AIII, timosaponin BIII, and mangiferin extracted from crude and salt-processed Anemarrhenae Rhizoma by UPLC-MS/MS. RSC Adv. 2023;13:11919\u201311928. doi: 10.1039/D2RA07979H.", "ArticleIdList": ["10.1039/D2RA07979H", "PMC10108379", "37077258"]}, {"Citation": "Lu L., Ding Y., Zhang Y., Ho R.J., Zhao Y., Zhang T., Guo C. Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. Int. J. Nanomed. 2018;13:1927\u20131944. doi: 10.2147/IJN.S153107.", "ArticleIdList": ["10.2147/IJN.S153107", "PMC5880182", "29636610"]}, {"Citation": "Huang X., He Y., Zhang M., Lu Z., Zhang T., Wang B. GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy. Expert Opin. Drug Deliv. 2023:1\u201319. doi: 10.1080/17425247.2023.2200997.", "ArticleIdList": ["10.1080/17425247.2023.2200997", "37039332"]}, {"Citation": "Ford H.L., Pardee A.B. Cancer and the cell cycle. J. Cell Biochem. 1999;32:166\u2013172. doi: 10.1002/(SICI)1097-4644(1999)75:32+<166::AID-JCB20>3.0.CO;2-J.", "ArticleIdList": ["10.1002/(SICI)1097-4644(1999)75:32+<166::AID-JCB20>3.0.CO;2-J", "10629116"]}, {"Citation": "Kaufmann S.H., Hengartner M.O. Programmed cell death: Alive and well in the new millennium. Trends Cell Biol. 2001;11:526\u2013534. doi: 10.1016/S0962-8924(01)02173-0.", "ArticleIdList": ["10.1016/S0962-8924(01)02173-0", "11719060"]}, {"Citation": "MarElia C.B., Sharp A.E., Shemwell T.A., Clare Zhang Y., Burkhardt B.R. Anemarrhena asphodeloides Bunge and its constituent timosaponin-AIII induce cell cycle arrest and apoptosis in pancreatic cancer cells. FEBS Open Bio. 2018;8:1155\u20131166. doi: 10.1002/2211-5463.12457.", "ArticleIdList": ["10.1002/2211-5463.12457", "PMC6026701", "29988574"]}, {"Citation": "Huang H.L., Chiang W.L., Hsiao P.C., Chien M.H., Chen H.Y., Weng W.C., Hsieh M.J., Yang S.F. Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells. Tumour Biol. 2015;36:3489\u20133497. doi: 10.1007/s13277-014-2985-7.", "ArticleIdList": ["10.1007/s13277-014-2985-7", "25542232"]}, {"Citation": "Zhang M., Qu J., Gao Z., Qi Q., Yin H., Zhu L., Wu Y., Liu W., Yang J., Huang X. Timosaponin AIII Induces G2/M Arrest and Apoptosis in Breast Cancer by Activating the ATM/Chk2 and p38 MAPK Signaling Pathways. Front. Pharmacol. 2020;11:601468. doi: 10.3389/fphar.2020.601468.", "ArticleIdList": ["10.3389/fphar.2020.601468", "PMC7898553", "33628174"]}, {"Citation": "Kim Y., Kim K.H., Lee I.S., Park J.Y., Na Y.C., Chung W.S., Jang H.J. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cells. Phytomedicine. 2019;56:48\u201356. doi: 10.1016/j.phymed.2018.08.006.", "ArticleIdList": ["10.1016/j.phymed.2018.08.006", "30668353"]}, {"Citation": "Kang Y.J., Chung H.J., Nam J.W., Park H.J., Seo E.K., Kim Y.S., Lee D., Lee S.K. Cytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cells. J. Nat. Prod. 2011;74:701\u2013706. doi: 10.1021/np1007735.", "ArticleIdList": ["10.1021/np1007735", "21370894"]}, {"Citation": "Nho K.J., Chun J.M., Kim H.K. Induction of mitochondria-dependent apoptosis in HepG2 human hepatocellular carcinoma cells by timosaponin A-III. Environ. Toxicol. Pharmacol. 2016;45:295\u2013301. doi: 10.1016/j.etap.2016.06.012.", "ArticleIdList": ["10.1016/j.etap.2016.06.012", "27344126"]}, {"Citation": "Harjunp\u00e4\u00e4 H., Llort Asens M., Guenther C., Fagerholm S.C. Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. Front. Immunol. 2019;10:1078. doi: 10.3389/fimmu.2019.01078.", "ArticleIdList": ["10.3389/fimmu.2019.01078", "PMC6558418", "31231358"]}, {"Citation": "Looi C.K., Hii L.W., Ngai S.C., Leong C.O., Mai C.W. The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player? Biomedicines. 2020;8:334. doi: 10.3390/biomedicines8090334.", "ArticleIdList": ["10.3390/biomedicines8090334", "PMC7555474", "32906721"]}, {"Citation": "Li X., Lu W., Zhou T., Zhao F., Yang L. Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma. Comput. Math. Methods Med. 2022;2022:6756676. doi: 10.1155/2022/6756676.", "ArticleIdList": ["10.1155/2022/6756676", "PMC9110172", "35586672"]}, {"Citation": "Lou W., Ding B., Xu L., Fan W. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network. Front. Mol. Neurosci. 2019;12:66. doi: 10.3389/fnmol.2019.00066.", "ArticleIdList": ["10.3389/fnmol.2019.00066", "PMC6444190", "30971889"]}, {"Citation": "Liao Y.F., Pan H.J., Abudurezeke N., Yuan C.L., Yuan Y.L., Zhao S.D., Zhang D.D., Huang S. Functional Axis of PDE5/cGMP Mediates Timosaponin-AIII-Elicited Growth Suppression of Glioblastoma U87MG Cells. Molecules. 2023;28:3795. doi: 10.3390/molecules28093795.", "ArticleIdList": ["10.3390/molecules28093795", "PMC10180307", "37175205"]}, {"Citation": "Shao W., Espenshade P.J. Expanding roles for SREBP in metabolism. Cell Metab. 2012;16:414\u2013419. doi: 10.1016/j.cmet.2012.09.002.", "ArticleIdList": ["10.1016/j.cmet.2012.09.002", "PMC3466394", "23000402"]}, {"Citation": "Cheng C., Ru P., Geng F., Liu J., Yoo J.Y., Wu X., Cheng X., Euthine V., Hu P., Guo J.Y., et al. Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth. Cancer Cell. 2015;28:569\u2013581. doi: 10.1016/j.ccell.2015.09.021.", "ArticleIdList": ["10.1016/j.ccell.2015.09.021", "PMC4643405", "26555173"]}, {"Citation": "Kim Y., Jee W., An E.J., Ko H.M., Jung J.H., Na Y.C., Jang H.J. Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer. Pharmaceutics. 2022;14:945. doi: 10.3390/pharmaceutics14050945.", "ArticleIdList": ["10.3390/pharmaceutics14050945", "PMC9147344", "35631531"]}, {"Citation": "Zhang L., Zhang S., Jiang M., Lu L., Ding Y., Ma N., Zhao Y., Xuchen S., Zhang N. Novel Timosaponin AIII-Based Multifunctional Liposomal Delivery System for Synergistic Therapy Against Hepatocellular Carcinoma Cancer. Int. J. Nanomed. 2021;16:5531\u20135550. doi: 10.2147/IJN.S313759.", "ArticleIdList": ["10.2147/IJN.S313759", "PMC8379713", "34429598"]}, {"Citation": "Jung J.H., Lee D., Ko H.M., Jang H.J. Inhibition of CNOT2 Induces Apoptosis via MID1IP1 in Colorectal Cancer Cells by Activating p53. Biomolecules. 2021;11:1492. doi: 10.3390/biom11101492.", "ArticleIdList": ["10.3390/biom11101492", "PMC8533695", "34680125"]}, {"Citation": "Kim M.J., Sim D.Y., Lee H.M., Lee H.J., Kim S.H. Hypolipogenic Effect of Shikimic Acid Via Inhibition of MID1IP1 and Phosphorylation of AMPK/ACC. Int. J. Mol. Sci. 2019;20:582. doi: 10.3390/ijms20030582.", "ArticleIdList": ["10.3390/ijms20030582", "PMC6387373", "30700011"]}, {"Citation": "Jung J.H., Lee H.J., Kim J.H., Sim D.Y., Im E., Kim S., Chang S., Kim S.H. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. Cells. 2020;9:985. doi: 10.3390/cells9040985.", "ArticleIdList": ["10.3390/cells9040985", "PMC7227012", "32316188"]}, {"Citation": "Ko H.M., Jee W., Park D.I., Kim K.I., Jung J.H., Jang H.J. The Antitumor Effect of Timosaponin A3 through c-Myc Inhibition in Colorectal Cancer Cells and Combined Treatment Effect with 5-FU or Doxorubicin. Int. J. Mol. Sci. 2022;23:11900. doi: 10.3390/ijms231911900.", "ArticleIdList": ["10.3390/ijms231911900", "PMC9569550", "36233202"]}, {"Citation": "Knaevelsrud H., Simonsen A. Fighting disease by selective autophagy of aggregate-prone proteins. FEBS Lett. 2010;584:2635\u20132645. doi: 10.1016/j.febslet.2010.04.041.", "ArticleIdList": ["10.1016/j.febslet.2010.04.041", "20412801"]}, {"Citation": "Lok C.N., Sy L.K., Liu F., Che C.M. Activation of autophagy of aggregation-prone ubiquitinated proteins by timosaponin A-III. J. Biol. Chem. 2011;286:31684\u201331696. doi: 10.1074/jbc.M110.202531.", "ArticleIdList": ["10.1074/jbc.M110.202531", "PMC3173142", "21757721"]}, {"Citation": "Wang N., Feng Y., Zhu M., Siu F.M., Ng K.M., Che C.M. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma. Biochim. Biophys. Acta. 2013;1833:2890\u20132899. doi: 10.1016/j.bbamcr.2013.07.018.", "ArticleIdList": ["10.1016/j.bbamcr.2013.07.018", "23906794"]}, {"Citation": "Sy L.K., Yan S.C., Lok C.N., Man R.Y., Che C.M. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer Res. 2008;68:10229\u201310237. doi: 10.1158/0008-5472.CAN-08-1983.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-1983", "19074891"]}, {"Citation": "Lee C.C., Tsai J.P., Lee H.L., Chen Y.J., Chen Y.S., Hsieh Y.H., Chen J.C. Blockage of Autophagy Increases Timosaponin AIII-Induced Apoptosis of Glioma Cells In Vitro and In Vivo. Cells. 2022;12:168. doi: 10.3390/cells12010168.", "ArticleIdList": ["10.3390/cells12010168", "PMC9818637", "36611961"]}, {"Citation": "Liu J., Deng X., Sun X., Dong J., Huang J. Inhibition of autophagy enhances timosaponin AIII-induced lung cancer cell apoptosis and anti-tumor effect in vitro and in vivo. Life Sci. 2020;257:118040. doi: 10.1016/j.lfs.2020.118040.", "ArticleIdList": ["10.1016/j.lfs.2020.118040", "32622943"]}, {"Citation": "Wang Y., Xu L., Lou L.L., Song S.J., Yao G.D., Ge M.Y., Hayashi T., Tashiro S.I., Onodera S., Ikejima T. Timosaponin AIII induces apoptosis and autophagy in human melanoma A375-S2 cells. Arch. Pharm. Res. 2017;40:69\u201378. doi: 10.1007/s12272-016-0763-3.", "ArticleIdList": ["10.1007/s12272-016-0763-3", "27271334"]}, {"Citation": "Wang H., Dong R., Fan W.W., Zheng X.C., Li A.M., Wang W.D. Timosaponin A-III induces autophagy of T-cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway. Oncol. Rep. 2019;41:2937\u20132944. doi: 10.3892/or.2019.7072.", "ArticleIdList": ["10.3892/or.2019.7072", "30896824"]}, {"Citation": "Bhattacharya R., Panda C.K., Nandi S., Mukhopadhyay A. An insight into metastasis: Random or evolving paradigms? Pathol. Res. Pract. 2018;214:1064\u20131073. doi: 10.1016/j.prp.2018.06.017.", "ArticleIdList": ["10.1016/j.prp.2018.06.017", "30078401"]}, {"Citation": "Gilcrease M.Z. Integrin signaling in epithelial cells. Cancer Lett. 2007;247:1\u201325. doi: 10.1016/j.canlet.2006.03.031.", "ArticleIdList": ["10.1016/j.canlet.2006.03.031", "16725254"]}, {"Citation": "Wen L., Yan W., Zhu L., Tang C., Wang G. The role of blood flow in vessel remodeling and its regulatory mechanism during developmental angiogenesis. Cell. Mol. Life Sci. CMLS. 2023;80:162. doi: 10.1007/s00018-023-04801-z.", "ArticleIdList": ["10.1007/s00018-023-04801-z", "37221410"]}, {"Citation": "Hsieh Y.H., Hsu W.H., Yang S.F., Liu C.J., Lu K.H., Wang P.H., Lin R.C. Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis. Pharmaceuticals. 2021;14:260. doi: 10.3390/ph14030260.", "ArticleIdList": ["10.3390/ph14030260", "PMC8000016", "33799345"]}, {"Citation": "Riedl K., Krysan K., P\u00f5ld M., Dalwadi H., Heuze-Vourc\u2019h N., Dohadwala M., Liu M., Cui X., Figlin R., Mao J.T., et al. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist. Updates. 2004;7:169\u2013184. doi: 10.1016/j.drup.2004.04.003.", "ArticleIdList": ["10.1016/j.drup.2004.04.003", "15296859"]}, {"Citation": "Majumder M., Xin X., Liu L., Girish G.V., Lala P.K. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. Cancer Sci. 2014;105:1142\u20131151. doi: 10.1111/cas.12475.", "ArticleIdList": ["10.1111/cas.12475", "PMC4462388", "24981602"]}, {"Citation": "Kim K.M., Im A.R., Kim S.H., Hyun J.W., Chae S. Timosaponin AIII inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis. Cancer Sci. 2016;107:181\u2013188. doi: 10.1111/cas.12852.", "ArticleIdList": ["10.1111/cas.12852", "PMC4768391", "26595378"]}, {"Citation": "Chiang K.C., Lai C.Y., Chiou H.L., Lin C.L., Chen Y.S., Kao S.H., Hsieh Y.H. Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis. J. Cell Physiol. 2019;234:13332\u201313341. doi: 10.1002/jcp.28010.", "ArticleIdList": ["10.1002/jcp.28010", "30604866"]}, {"Citation": "Ying T.H., Lee C.H., Chiou H.L., Yang S.F., Lin C.L., Hung C.H., Tsai J.P., Hsieh Y.H. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells. Sci. Rep. 2016;6:29385. doi: 10.1038/srep29385.", "ArticleIdList": ["10.1038/srep29385", "PMC4932528", "27377307"]}, {"Citation": "Chien H.J., Liu C.J., Ying T.H., Wu P.J., Wang J.W., Ting Y.H., Hsieh Y.H., Wang S.C. Timosaponin AIII Inhibits Migration and Invasion Abilities in Human Cervical Cancer Cells through Inactivation of p38 MAPK-Mediated uPA Expression In Vitro and In Vivo. Cancers. 2022;15:37. doi: 10.3390/cancers15010037.", "ArticleIdList": ["10.3390/cancers15010037", "PMC9817900", "36612038"]}, {"Citation": "Jung O., Lee J., Lee Y.J., Yun J.M., Son Y.J., Cho J.Y., Ryou C., Lee S.Y. Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and \u03b2-catenin signaling pathways. Bioorg. Med. Chem. Lett. 2016;26:3963\u20133967. doi: 10.1016/j.bmcl.2016.07.004.", "ArticleIdList": ["10.1016/j.bmcl.2016.07.004", "27422337"]}, {"Citation": "Abdouh M., Facchino S., Chatoo W., Balasingam V., Ferreira J., Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci. Off. J. Soc. Neurosci. 2009;29:8884\u20138896. doi: 10.1523/JNEUROSCI.0968-09.2009.", "ArticleIdList": ["10.1523/JNEUROSCI.0968-09.2009", "PMC6665439", "19605626"]}, {"Citation": "Song L.B., Zeng M.S., Liao W.T., Zhang L., Mo H.Y., Liu W.L., Shao J.Y., Wu Q.L., Li M.Z., Xia Y.F., et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66:6225\u20136232. doi: 10.1158/0008-5472.CAN-06-0094.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0094", "16778197"]}, {"Citation": "Gergely J.E., Dorsey A.E., Dimri G.P., Dimri M. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells. Mol. Carcinog. 2018;57:831\u2013841. doi: 10.1002/mc.22804.", "ArticleIdList": ["10.1002/mc.22804", "PMC5986597", "29528145"]}, {"Citation": "Tsai C.H., Yang C.W., Wang J.Y., Tsai Y.F., Tseng L.M., King K.L., Chen W.S., Chiu J.H., Shyr Y.M. Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells. Evid.-Based Complement. Altern. Med. eCAM. 2013;2013:421051. doi: 10.1155/2013/421051.", "ArticleIdList": ["10.1155/2013/421051", "PMC3708436", "23878598"]}, {"Citation": "Lee S.Y. Ginsenoside Rg1 Drives Stimulations of Timosaponin AIII-Induced Anticancer Effects in Human Osteosarcoma Cells. Evid.-Based Complement. Altern. Med. eCAM. 2020;2020:8980124. doi: 10.1155/2020/8980124.", "ArticleIdList": ["10.1155/2020/8980124", "PMC7396057", "32774433"]}, {"Citation": "Jung O., Lee S.Y. Synergistic anticancer effects of timosaponin AIII and ginsenosides in MG63 human osteosarcoma cells. J. Ginseng Res. 2019;43:488\u2013495. doi: 10.1016/j.jgr.2018.11.002.", "ArticleIdList": ["10.1016/j.jgr.2018.11.002", "PMC6606842", "31308821"]}, {"Citation": "Feng Y., Luo S., Fan D., Guo X., Ma S. The role of vascular endothelial cells in tumor metastasis. Acta Histochem. 2023;125:152070. doi: 10.1016/j.acthis.2023.152070.", "ArticleIdList": ["10.1016/j.acthis.2023.152070", "37348328"]}, {"Citation": "Zhou Z.Y., Zhao W.R., Xiao Y., Zhou X.M., Huang C., Shi W.T., Zhang J., Ye Q., Chen X.L., Tang J.Y. Antiangiogenesis effect of timosaponin AIII on HUVECs in vitro and zebrafish embryos in vivo. Acta Pharmacol. Sin. 2020;41:260\u2013269. doi: 10.1038/s41401-019-0291-z.", "ArticleIdList": ["10.1038/s41401-019-0291-z", "PMC7471416", "31515528"]}, {"Citation": "Ravi Kiran Ammu V.V.V., Garikapati K.K., Krishnamurthy P.T., Chintamaneni P.K., Pindiprolu S. Possible role of PPAR-\u03b3 and COX-2 receptor modulators in the treatment of Non-Small Cell lung carcinoma. Med. Hypotheses. 2019;124:98\u2013100. doi: 10.1016/j.mehy.2019.02.024.", "ArticleIdList": ["10.1016/j.mehy.2019.02.024", "30798928"]}, {"Citation": "Amano H., Nakamura M., Ito Y., Kakutani H., Eshima K., Kitasato H., Narumiya S., Majima M. Thromboxane A synthase enhances blood flow recovery from hindlimb ischemia. J. Surg. Res. 2016;204:153\u2013163. doi: 10.1016/j.jss.2016.04.011.", "ArticleIdList": ["10.1016/j.jss.2016.04.011", "27451882"]}, {"Citation": "Cong Y., Wang L., Peng R., Zhao Y., Bai F., Yang C., Liu X., Wang D., Ma B., Cong Y. Timosaponin AIII induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor. Sci. Rep. 2016;6:38757. doi: 10.1038/srep38757.", "ArticleIdList": ["10.1038/srep38757", "PMC5146924", "27934923"]}, {"Citation": "Wu Q., Yang Z., Nie Y., Shi Y., Fan D. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer Lett. 2014;347:159\u2013166. doi: 10.1016/j.canlet.2014.03.013.", "ArticleIdList": ["10.1016/j.canlet.2014.03.013", "24657660"]}, {"Citation": "Dewanjee S., Dua T.K., Bhattacharjee N., Das A., Gangopadhyay M., Khanra R., Joardar S., Riaz M., Feo V., Zia-Ul-Haq M. Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. Molecules. 2017;22:871. doi: 10.3390/molecules22060871.", "ArticleIdList": ["10.3390/molecules22060871", "PMC6152721", "28587082"]}, {"Citation": "Dai J., He Y., Fang J., Wang H., Chao L., Zhao L., Hong Z., Chai Y. In Vitro Evaluation of the Interaction of Seven Biologically Active Components in Anemarrhenae rhizoma with P-gp. Molecules. 2022;27:8556. doi: 10.3390/molecules27238556.", "ArticleIdList": ["10.3390/molecules27238556", "PMC9740098", "36500651"]}, {"Citation": "Chen J.R., Jia X.H., Wang H., Yi Y.J., Wang J.Y., Li Y.J. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Int. J. Oncol. 2016;48:2063\u20132070. doi: 10.3892/ijo.2016.3423.", "ArticleIdList": ["10.3892/ijo.2016.3423", "26984633"]}, {"Citation": "Song X.Y., Han F.Y., Chen J.J., Wang W., Zhang Y., Yao G.D., Song S.J. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo. Steroids. 2019;146:57\u201364. doi: 10.1016/j.steroids.2019.03.009.", "ArticleIdList": ["10.1016/j.steroids.2019.03.009", "30951756"]}, {"Citation": "Xie L., Lee D.Y., Shang Y., Cao X., Wang S., Liao J., Zhang T., Dai R. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS. Phytomedicine. 2020;77:153284. doi: 10.1016/j.phymed.2020.153284.", "ArticleIdList": ["10.1016/j.phymed.2020.153284", "32707371"]}, {"Citation": "Huai J., Zhao X., Wang S., Xie L., Li Y., Zhang T., Cheng C., Dai R. Characterization and screening of cyclooxygenase-2 inhibitors from Zi-shen pill by affinity ultrafiltration-ultra performance liquid chromatography mass spectrometry. J. Ethnopharmacol. 2019;241:111900. doi: 10.1016/j.jep.2019.111900.", "ArticleIdList": ["10.1016/j.jep.2019.111900", "31029761"]}, {"Citation": "Wang S., Huai J., Shang Y., Xie L., Cao X., Liao J., Zhang T., Dai R. Screening for natural inhibitors of 5-lipoxygenase from Zi-shen pill extract by affinity ultrafiltration coupled with ultra performance liquid chromatography-mass spectrometry. J. Ethnopharmacol. 2020;254:112733. doi: 10.1016/j.jep.2020.112733.", "ArticleIdList": ["10.1016/j.jep.2020.112733", "32145333"]}, {"Citation": "Li R., Zhao Y., Zhang X., Yang L., Zou X. NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury. Immunol. Investig. 2023;52:567\u2013582. doi: 10.1080/08820139.2023.2206445.", "ArticleIdList": ["10.1080/08820139.2023.2206445", "37139806"]}, {"Citation": "Ji K.Y., Kim K.M., Kim Y.H., Im A.R., Lee J.Y., Park B., Na M., Chae S. The enhancing immune response and anti-inflammatory effects of Anemarrhena asphodeloides extract in RAW 264.7 cells. Phytomedicine. 2019;59:152789. doi: 10.1016/j.phymed.2018.12.012.", "ArticleIdList": ["10.1016/j.phymed.2018.12.012", "31009851"]}, {"Citation": "Lee B., Jung K., Kim D.H. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice. Pharmacol. Biochem. Behav. 2009;93:121\u2013127. doi: 10.1016/j.pbb.2009.04.021.", "ArticleIdList": ["10.1016/j.pbb.2009.04.021", "19426756"]}, {"Citation": "Yu Y.Y., Cui S.C., Zheng T.N., Ma H.J., Xie Z.F., Jiang H.W., Li Y.F., Zhu K.X., Huang C.G., Li J., et al. Sarsasapogenin improves adipose tissue inflammation and ameliorates insulin resistance in high-fat diet-fed C57BL/6J mice. Acta Pharmacol. Sin. 2021;42:272\u2013281. doi: 10.1038/s41401-020-0427-1.", "ArticleIdList": ["10.1038/s41401-020-0427-1", "PMC8027656", "32699264"]}, {"Citation": "Park B.K., So K.S., Ko H.J., Kim H.J., Kwon K.S., Kwon Y.S., Son K.H., Kwon S.Y., Kim H.P. Therapeutic Potential of the Rhizomes of Anemarrhena asphodeloides and Timosaponin A-III in an Animal Model of Lipopolysaccharide-Induced Lung Inflammation. Biomol. Ther. 2018;26:553\u2013559. doi: 10.4062/biomolther.2017.249.", "ArticleIdList": ["10.4062/biomolther.2017.249", "PMC6254648", "29925223"]}, {"Citation": "Kim K.M., Im A.R., Park S.K., Shin H.S., Chae S.W. Protective Effects of Timosaponin AIII against UVB-Radiation Induced Inflammation and DNA Injury in Human Epidermal Keratinocytes. Biol. Pharm. Bull. 2019;42:1524\u20131531. doi: 10.1248/bpb.b19-00222.", "ArticleIdList": ["10.1248/bpb.b19-00222", "31270288"]}, {"Citation": "Im A.R., Seo Y.K., Cho S.H., O K.H., Kim K.M., Chae S. Clinical evaluation of the safety and efficacy of a timosaponin A-III-based antiwrinkle agent against skin aging. J. Cosmet. Dermatol. 2020;19:423\u2013436. doi: 10.1111/jocd.13035.", "ArticleIdList": ["10.1111/jocd.13035", "PMC7003920", "31215156"]}, {"Citation": "Liu F., Feng M., Xing J., Zhou X. Timosaponin alleviates oxidative stress in rats with high fat diet-induced obesity via activating Nrf2/HO-1 and inhibiting the NF-\u03baB pathway. Eur. J. Pharmacol. 2021;909:174377. doi: 10.1016/j.ejphar.2021.174377.", "ArticleIdList": ["10.1016/j.ejphar.2021.174377", "34302815"]}, {"Citation": "Wu Z.T., Qi X.M., Sheng J.J., Ma L.L., Ni X., Ren J., Huang C.G., Pan G.Y. Timosaponin A3 induces hepatotoxicity in rats through inducing oxidative stress and down-regulating bile acid transporters. Acta Pharmacol. Sin. 2014;35:1188\u20131198. doi: 10.1038/aps.2014.65.", "ArticleIdList": ["10.1038/aps.2014.65", "PMC4155534", "25087997"]}, {"Citation": "Zhou C., Yu T., Zhu R., Lu J., Ouyang X., Zhang Z., Chen Q., Li J., Cui J., Jiang F., et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int. J. Biol. Sci. 2023;19:1471\u20131489. doi: 10.7150/ijbs.77979.", "ArticleIdList": ["10.7150/ijbs.77979", "PMC10086754", "37056925"]}, {"Citation": "Li H., Wu C., Liu Y., Zhang S., Gao X. Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes. BMC Complement. Altern. Med. 2019;19:240. doi: 10.1186/s12906-019-2651-0.", "ArticleIdList": ["10.1186/s12906-019-2651-0", "PMC6727345", "31484532"]}, {"Citation": "Lee B., Trinh H.T., Jung K., Han S.J., Kim D.H. Inhibitory effects of steroidal timosaponins isolated from the rhizomes of Anemarrhena asphodeloides against passive cutaneous anaphylaxis reaction and pruritus. Immunopharmacol. Immunotoxicol. 2010;32:357\u2013363. doi: 10.3109/08923970903383889.", "ArticleIdList": ["10.3109/08923970903383889", "20095799"]}, {"Citation": "Xie H.F., Li W., Pan H., Xie Q., Hu Y. Preparation Method of Timosaponin AIII. CN114085883A. Chinese Patent. 2022 February 25;"}, {"Citation": "Yuan F.Y., Li X.Y., Gao T., Liu Z., Liu W., Zhou D., Yang K., Guo R., Li C., Tian Y. Application of Timosaponin AIII in Preparation of Medicine for Inhibiting Haemophilus Parasuis. CN115317499A. Chinese Patent. 2022 November 11;"}, {"Citation": "Ding Y., Zhao W.J., Zhang T., Lu L., Jiang M., Zhang L., Zhang S. Medical Application of Timosaponin Enzymatic Hydrolysate and Main Component Timosaponin AIII (TAIII) Thereof. CN112168833A. Chinese Patent. 2021 January 25;"}, {"Citation": "Tao L., Duan G.C., Gu Y., Liu Y., Wang W., Li G. Application of Timosaponin A-III in Preparation of Anti-Human Rhabdomyosarcoma Drug. CN107412245A. Chinese Patent. 2017 December 1;"}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "6"}, {"Year": "2023", "Month": "7", "Day": "17"}, {"Year": "2023", "Month": "7", "Day": "18"}, {"Year": "2023", "Month": "7", "Day": "31", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "49"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "35"}, {"Year": "2023", "Month": "7", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["37513375", "PMC10386027", "10.3390/molecules28145500", "molecules28145500"]}}], "PubmedBookArticle": []}